 | • レポートコード：QYR9ST03481 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、小細胞肺がん治療薬の世界市場について調査・分析し、小細胞肺がん治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（生物製剤、小分子）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の小細胞肺がん治療薬市場動向 ・主要企業別マーケットシェア ・小細胞肺がん治療薬の種類別市場規模2014-2019 （生物製剤、小分子） ・小細胞肺がん治療薬の用途別市場規模2014-2019 （病院、クリニック、その他） ・小細胞肺がん治療薬の北米市場：主要企業・種類別/用途別市場規模 ・小細胞肺がん治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・小細胞肺がん治療薬の中国市場：主要企業・種類別/用途別市場規模 ・小細胞肺がん治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・小細胞肺がん治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・小細胞肺がん治療薬のインド市場：主要企業・種類別/用途別市場規模 ・小細胞肺がん治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Sanofi、Bristol-Myers Squibb、GlaxoSmithKline、Menarini、Ziopharm Oncology、Merck、Novartis、AstraZeneca、Takeda Pharmaceutical、Teva Pharmaceutical、Eli Lilly、Mylan、Sun Pharmaceuticals Industries、Amgen、Ono Pharmaceutical、Shanghai Jinhe Bio-Technology） ・小細胞肺がん治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell carcinoma. It can be further classified into two stages: limited-stage small cell lung cancer and extensive-stage small cell lung cancer. Small cell lung cancer is caused by smoking tobacco, or second hand smoking, or on exposure to asbestos, chromium, arsenic, nickel, soot, or radon. The common symptoms associated with lung cancer are chest pain, incurable cough, blood in sputum, fatigue, loss of appetite, unintentional weight loss, shortness of breath, and wheezing. Small cell lung cancer has a poor prognosis and gets diagnosed only at the late stage of disease progression, and hence, has a high mortality rate. There are no therapies available to cure small cell lung cancer in the market.In 2018, the global Small Cell Lung Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Small Cell Lung Cancer Therapeutics development in United States, Europe and China.
The key players covered in this study
Sanofi
Bristol-Myers Squibb
GlaxoSmithKline
Menarini
Ziopharm Oncology
Merck
Novartis
AstraZeneca
Takeda Pharmaceutical
Teva Pharmaceutical
Eli Lilly
Mylan
Sun Pharmaceuticals Industries
Amgen
Ono Pharmaceutical
Shanghai Jinhe Bio-Technology
Market segment by Type, the product can be split into
Biologics
Small molecules
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Small Cell Lung Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Small Cell Lung Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Biologics
1.4.3 Small molecules
1.5 Market by Application
1.5.1 Global Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Small Cell Lung Cancer Therapeutics Market Size
2.2 Small Cell Lung Cancer Therapeutics Growth Trends by Regions
2.2.1 Small Cell Lung Cancer Therapeutics Market Size by Regions (2014-2025)
2.2.2 Small Cell Lung Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Small Cell Lung Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Small Cell Lung Cancer Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Small Cell Lung Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Small Cell Lung Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
5.2 Small Cell Lung Cancer Therapeutics Key Players in United States
5.3 United States Small Cell Lung Cancer Therapeutics Market Size by Type
5.4 United States Small Cell Lung Cancer Therapeutics Market Size by Application
6 Europe
6.1 Europe Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
6.2 Small Cell Lung Cancer Therapeutics Key Players in Europe
6.3 Europe Small Cell Lung Cancer Therapeutics Market Size by Type
6.4 Europe Small Cell Lung Cancer Therapeutics Market Size by Application
7 China
7.1 China Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
7.2 Small Cell Lung Cancer Therapeutics Key Players in China
7.3 China Small Cell Lung Cancer Therapeutics Market Size by Type
7.4 China Small Cell Lung Cancer Therapeutics Market Size by Application
8 Japan
8.1 Japan Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
8.2 Small Cell Lung Cancer Therapeutics Key Players in Japan
8.3 Japan Small Cell Lung Cancer Therapeutics Market Size by Type
8.4 Japan Small Cell Lung Cancer Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
9.2 Small Cell Lung Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Application
10 India
10.1 India Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
10.2 Small Cell Lung Cancer Therapeutics Key Players in India
10.3 India Small Cell Lung Cancer Therapeutics Market Size by Type
10.4 India Small Cell Lung Cancer Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
11.2 Small Cell Lung Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Small Cell Lung Cancer Therapeutics Market Size by Type
11.4 Central & South America Small Cell Lung Cancer Therapeutics Market Size by Application
12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 Small Cell Lung Cancer Therapeutics Introduction
12.1.4 Sanofi Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.1.5 Sanofi Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Small Cell Lung Cancer Therapeutics Introduction
12.2.4 Bristol-Myers Squibb Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.2.5 Bristol-Myers Squibb Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Small Cell Lung Cancer Therapeutics Introduction
12.3.4 GlaxoSmithKline Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Menarini
12.4.1 Menarini Company Details
12.4.2 Company Description and Business Overview
12.4.3 Small Cell Lung Cancer Therapeutics Introduction
12.4.4 Menarini Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.4.5 Menarini Recent Development
12.5 Ziopharm Oncology
12.5.1 Ziopharm Oncology Company Details
12.5.2 Company Description and Business Overview
12.5.3 Small Cell Lung Cancer Therapeutics Introduction
12.5.4 Ziopharm Oncology Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.5.5 Ziopharm Oncology Recent Development
12.6 Merck
12.6.1 Merck Company Details
12.6.2 Company Description and Business Overview
12.6.3 Small Cell Lung Cancer Therapeutics Introduction
12.6.4 Merck Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.6.5 Merck Recent Development
12.7 Novartis
12.7.1 Novartis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Small Cell Lung Cancer Therapeutics Introduction
12.7.4 Novartis Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.7.5 Novartis Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Small Cell Lung Cancer Therapeutics Introduction
12.8.4 AstraZeneca Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.8.5 AstraZeneca Recent Development
12.9 Takeda Pharmaceutical
12.9.1 Takeda Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Small Cell Lung Cancer Therapeutics Introduction
12.9.4 Takeda Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.9.5 Takeda Pharmaceutical Recent Development
12.10 Teva Pharmaceutical
12.10.1 Teva Pharmaceutical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Small Cell Lung Cancer Therapeutics Introduction
12.10.4 Teva Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.10.5 Teva Pharmaceutical Recent Development
12.11 Eli Lilly
12.12 Mylan
12.13 Sun Pharmaceuticals Industries
12.14 Amgen
12.15 Ono Pharmaceutical
12.16 Shanghai Jinhe Bio-Technology
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Small Cell Lung Cancer Therapeutics Key Market Segments
Table Key Players Small Cell Lung Cancer Therapeutics Covered
Table Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Small Cell Lung Cancer Therapeutics Market Size Market Share by Type 2014-2025
Figure Biologics Figures
Table Key Players of Biologics
Figure Small molecules Figures
Table Key Players of Small molecules
Table Global Small Cell Lung Cancer Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Small Cell Lung Cancer Therapeutics Report Years Considered
Table Global Small Cell Lung Cancer Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Small Cell Lung Cancer Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Small Cell Lung Cancer Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Small Cell Lung Cancer Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Small Cell Lung Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Small Cell Lung Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Small Cell Lung Cancer Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Small Cell Lung Cancer Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Small Cell Lung Cancer Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Small Cell Lung Cancer Therapeutics Market Share by Manufacturers in 2018
Table Global Small Cell Lung Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Small Cell Lung Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Small Cell Lung Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Small Cell Lung Cancer Therapeutics Market Size Share by Type (2014-2019)
Figure Global Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Small Cell Lung Cancer Therapeutics Market Size Share by Application (2014-2019)
Figure Global Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Application in 2018
Figure United States Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table United States Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table United States Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Figure Europe Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Figure China Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table China Small Cell Lung Cancer Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table China Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Figure Japan Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table Japan Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table Japan Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Figure India Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table India Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table India Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Small Cell Lung Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Small Cell Lung Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Small Cell Lung Cancer Therapeutics Market Share (2018-2019)
Table Central & South America Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Small Cell Lung Cancer Therapeutics Market Share by Type (2014-2019)
Table Central & South America Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2019)
Table Sanofi Company Details
Table Sanofi Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019) (Million US$)
Figure Sanofi Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Sanofi Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Menarini Company Details
Table Menarini Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Menarini Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Menarini Recent Development
Table Ziopharm Oncology Company Details
Table Ziopharm Oncology Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Ziopharm Oncology Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Ziopharm Oncology Recent Development
Table Merck Company Details
Table Merck Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Eli Lilly Company Details
Table Mylan Company Details
Table Sun Pharmaceuticals Industries Company Details
Table Amgen Company Details
Table Ono Pharmaceutical Company Details
Table Shanghai Jinhe Bio-Technology Company Details
Table Global Small Cell Lung Cancer Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Small Cell Lung Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Small Cell Lung Cancer Therapeutics Market Size Share by Regions in 2025
Figure United States Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Small Cell Lung Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Small Cell Lung Cancer Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Small Cell Lung Cancer Therapeutics Market Size by Product (2019-2025)
Figure Global Small Cell Lung Cancer Therapeutics Market Size by Product in 2025
Table Global Small Cell Lung Cancer Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Small Cell Lung Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Small Cell Lung Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
非小細胞肺癌治療薬の世界市場：市場規模・現状・予測 Lung cancer or lung carcinoma is a disease characterized by uncontrolled cell growth in the lungs. Common symptoms include cough, chest pain, weight loss, and shortness of breath. Due an increase in the incidence of lung cancer, the global lung cancer therapeutics market is expected to expand at a r…- スモールセルネットワークの世界市場：市場規模・現状・予測 Small cells are low-powered cellular radio access nodes that operate in licensed and unlicensed spectrum that have a range of 10 meters to a few kilometers. They are "small" compared to a mobile macrocell, partly because they have a shorter range and partly because they typically handle fewer concur…
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- 肺癌液体生検の世界市場：市場規模・現状・予測 Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time. In 2018, the global Lung Ca…